News Column

Studies from Institute of Neurology Yield New Data on Gene Therapy

June 26, 2014



By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Fresh data on Biotechnology are presented in a new report. According to news reporting out of London, United Kingdom, by NewsRx editors, research stated, "Epilepsy represents a major burden to society, not least because approximately 25% of patients do not respond satisfactorily to antiepileptic medication, and only a minority with pharmacoresistant epilepsy are eligible for potentially curative surgery."

Our news journalists obtained a quote from the research from the Institute of Neurology, "Several studies have explored gene therapy as a treatment strategy. The translation of scientific breakthroughs into the clinic faces several challenges, including the validation of experimental models of human pharmacoresistant epilepsy, establishment of sensitive and specific measures of therapeutic efficacy, and evaluation of the long-term safety of gene therapy."

According to the news editors, the research concluded: "On the basis of successful reports of gene therapy in experimental models of epilepsy, a roadmap toward clinical trials is proposed."

For more information on this research see: Gene therapy in epilepsy-is it time for clinical trials? Nature Reviews Neurology, 2014;10(5):300-304. Nature Reviews Neurology can be contacted at: Nature Publishing Group, 75 Varick St, 9TH Flr, New York, NY 10013-1917, USA. (Nature Publishing Group - www.nature.com/; Nature Reviews Neurology - www.nature.com/nrneurol/)

Our news journalists report that additional information may be obtained by contacting D.M. Kullmann, UCL, Dept. of Clin & Expt Epilepsy, Inst Neurol, London WC1N 3BG, United Kingdom. Additional authors for this research include S. Schorge, M.C. Walker and R.C. Wykes (see also Biotechnology).

Keywords for this news article include: Biotechnology, London, Europe, Epilepsy, Gene Therapy, United Kingdom, Bioengineering, Brain Diseases, Clinical Trials and Studies, Central Nervous System Diseases

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Gene Therapy Weekly


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters